FDA clears Integra's LICOX system:

Integra Neurosciences, a division of Plainsboro, New Jersey-based Integra LifeSciences Holdings, has received US FDA 510 (k) clearance to market its LICOX brain tissue oxygen monitoring system. The device, which is manufactured by German-based GMSmbH, provides continuous quantitative regional monitoring of dissolved oxygen and temperature in body fluids and tissues. The small size and long-term stability of the system's sensors make the product useful for critical care and intraoperative monitoring, says the company, which plans to launch the product in the first quarter of the year.

Integra Neurosciences, a division of Plainsboro, New Jersey-based Integra LifeSciences Holdings, has received US FDA 510 (k) clearance to market its LICOX brain tissue oxygen monitoring system. The device, which is manufactured by German-based GMSmbH, provides continuous quantitative regional monitoring of dissolved oxygen and temperature in body fluids and tissues. The small size and long-term stability of the system's sensors make the product useful for critical care and intraoperative monitoring, says the company, which plans to launch the product in the first quarter of the year.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight